Who AbbVie buys from and sells to
Sells immunology, neuroscience, oncology and aesthetics drugs (Skyrizi, Rinvoq, Botox), mostly via US wholesalers.
Buys from 1
- Single-source ingredient supplierscertain materials for biologics, unnamed in the 10-K
Where the chain could break
- Skyrizi and Rinvoq were ~42% of 2025 net revenues
- Three wholesalers take substantially all US drug sales and 84% of receivables
Competes with
- Johnson & JohnsonJNJTremfya against Skyrizi in psoriasis and IBD
- AmgenAMGNAmjevita, a Humira biosimilar
- Bristol Myers SquibbBMYCobenfy against Vraylar in schizophrenia
Mapped by hand from filings and company reporting, as of October 2026. It shows the relationships that matter most, not every contract: most are never disclosed, and agreements change.